e-learning
resources
London 2016
Sunday, 04.09.2016
In-patient and out-patient COPD management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients
Tang-Hsiu Huang (Tainan, Taiwan), Tang-Hsiu Huang, Chiung-Zuei Chen, Han-Yu Chang, Tzuen-Ren Hsiue
Source:
International Congress 2016 – In-patient and out-patient COPD management
Session:
In-patient and out-patient COPD management
Session type:
Poster Discussion
Number:
552
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Tang-Hsiu Huang (Tainan, Taiwan), Tang-Hsiu Huang, Chiung-Zuei Chen, Han-Yu Chang, Tzuen-Ren Hsiue. Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients. Eur Respir J 2016; 48: Suppl. 60, 552
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Usefulness of severity predictive scores in COPD exacerbations in hospitalized patients
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Clinical characteristics of patients with clinically-diagnosed COPD exacerbations but without concomitant airflow limitation
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Spirometry quality in patients with COPD exacerbation, related to the “frequent exacerbator” phenotype
Source: Annual Congress 2013 –Reference, reliability and risk: advances in lung function
Year: 2013
The clinical significance and frequency of bronchiectasis in COPD patients
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Comparison of pre and post-bronchodilator single-breath and re-breathe DLCO values amongst healthy, asthmatic and COPD subjects
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013
Usefulness of post bronchodilator FVC in the evaluation and spirometric evolution of COPD patients
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
Rate of FEV1 decline by FEV1 percent predicted in UPLIFT® and TIOSPIR®
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016
Can emphysema predict exacerbations and changes in PFTs in COPD?
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Five FEV1 adjustment methods for grading airway obstruction severity in USA Caucasian patients
Source: International Congress 2015 – Lung function: waiting to exhale...
Year: 2015
Comparison of spirometric markers of severity and reversibility in patients with asthma and/or COPD in NOVELTY
Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases
Year: 2020
GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012
Change in clinical COPD questionnaire (CCQ) symptoms domain score and FEV
1
predict treatment failure during hospitalisation due to COPD exacerbations
Source: Eur Respir J 2007; 30: Suppl. 51, 525s
Year: 2007
Relationship between change in trough FEV1 and COPD patient outcomes: Pooled analysis of 23 clinical trials in patients with COPD
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
Impact of the nutritional status on pulmonary function in COPD patients
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013
Changes in FEV1 and SpO2 in patients with severe and very severe COPD
Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases
Year: 2021
Alternative ways of expressing FEV1 and mortality in elderly people with and without COPD
Source: Eur Respir J 2013; 41: 800-805
Year: 2013
Significance of quantitative radiological phenotypes of COPD on BODE index
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Correlation between spirometric indices (FEV1, FVC) and lung diffusion values (DLCO) in subjects with varying severity of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007
Spirometric changes in bronchodilation tests as predictors of asthma diagnosis and treatment response in patients with FEV1 =80% predicted
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept